New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
On December 22, 2021, Teva launched an AB-rated generic version of Emergent BioSolutions’ Narcan (naloxone) 4 mg nasal spray.
Download PDF
Return to publications
